AJN senior clinical editor Christine Moffa speaks with Andrew Penn about his article, which discusses the growing interest in psychedelic therapies—such as LSD, MDMA, and psilocybin—for the treatment of mental health disorders, including trauma, depression, and addiction, as well as the potential role of nursing in this emerging field.